patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: News

News

posted on Mar 09, 2010 03:36PM

HAIFA, Israel, March 8, 2010-- Pluristem Therapeutics Inc. (Nasdaq:PSTI - News) (DAX:PJT), today announced its participation in the Roth 22nd Annual OC Growth Conference to be held at The Ritz-Carlton in Laguna Niguel, CA March 15-17.

William R. Prather RPh, MD, Senior VP Corporate Development, will deliver a presentation on Wednesday, March 17 at 9:00 a.m. PT/12:00 p.m. ET which can be viewed live at http://www.wsw.com/webcast/roth23/psti/ or through the investor relations section of Pluristem’s website at www.pluristem.com. The presentation will be archived for 90 days.

Share
New Message
Please login to post a reply